RecruitingPhase 2NCT06192160
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Studying Primary pulmonary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Radojka Savic, PharmD, PhDUniversity of California
- Intervention
- Isoniazid(drug)
- Enrollment
- 315 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (28)
- 12701, Gaborone CRS, Gaborone, Botswana
- 12201, Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Brazil
- 12101, Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil
- 30022, Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, Port-au-Prince, Haiti
- 31730, GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS, Port-au-Prince, Haiti
- 31441, Byramjee Jeejeebhoy Medical College (BJMC) CRS, Pune, India
- 12601, Moi University Clinical Research Center (MUCRC) CRS, Eldoret, Kenya
- 12501, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS, Kericho, Kenya
- 30301, Blantyre CRS, Blantyre, Malawi
- 12001, Malawi CRS, Lilongwe, Malawi
- 32078, Nutrición-Mexico CRS, Mexico City, Mexico
- 11301, Barranco CRS, Lima, Peru
- 31985, Socios En Salud Sucursal Perú CRS, Lima, Peru
- 31981, TB HIV Innovations and Clinical Research Foundation Corp., Cavite, Philippines
- 31793, South African Tuberculosis Vaccine Initiative (SATVI) CRS, Cape Town, South Africa
- +13 more locations on ClinicalTrials.gov
Collaborators
TB Alliance
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06192160 on ClinicalTrials.govOther trials for Primary pulmonary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University
- RECRUITINGPHASE3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGPHASE2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPHASE2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science
- ACTIVE NOT RECRUITINGNANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University
- ACTIVE NOT RECRUITINGPHASE3NCT06649721Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortHuashan Hospital
- RECRUITINGPHASE4NCT06476210The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)Beijing Chest Hospital
- RECRUITINGPHASE2NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBUniversity College, London